Navigation Links
Dr. Oz Misses Key Point On Mercury Amalgam’s Impact On Human Health
Date:4/8/2013

Santa Monica, CA (PRWEB) April 08, 2013

About half of all mercury entering wastewaters comes from dental practices, according to the EPA. It’s via this channel that mercury pollution harms the health of all people, not just those with amalgam fillings. However, an inexpensive piece of equipment – an amalgam separator– can virtually eliminate a dental office’s contribution to this problem.

It’s no secret that elemental mercury, which makes up about half of an amalgam filling, is a known toxin. During dental procedures, small particles of mercury can flow down the drain, bypassing chair side traps and making their way into wastewaters. Though treatment plants capture most of the mercury, about 10% is distributed into the environment via sludge that is either incinerated, applied to the land as fertilizer, or deposited in landfills. From there, mercury finds its way to waterways, where is converts to methylmercury, a neurotoxin that builds up in fish and the mammals that consume them, including humans. Methylmercury has been linked to health and developmental problems, particularly in pregnant women, fetuses and young children.

Fortunately, amalgam separators can solve this problem, eliminating the impact of dental amalgam on the environment. Once installed, separators remove more than 99% of mercury from a practice’s wastewater. They are maintenance-free, other than the annual recycling of the collection container. Though only a dozen states currently require separators, the EPA is
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Cancer checkpoint
2. AvePoint Announces Platinum Sponsorship of SHARE Conference Atlanta 2013
3. New Web Services Feature in Corepoint Integration Engine Simplifies Health Information Exchange For Leading Providers
4. AvePoint Extends Collaboration to the Cloud with DocAve Online for Microsoft SharePoint
5. Study Pinpoints Women at Risk for Blood Clots From Pregnancy
6. Heart Risks May Also Point to Dementia Risk
7. Skechers Injury Lawsuit Update: Richard W. Schulte, Partner with Wright & Schulte LLC, Appointed to Plaintiffs’ Steering Committee in California Skechers Toning Shoes Litigation
8. Albright Technologies, the Leader in Medical Silicone Molding, Appoints New President
9. New Method May Help Pinpoint Womans Final Menstrual Period
10. Cearna Appoints Mark Chenoweth as Director of Sales for the Company’s Facial Plastic Surgery Recovery Products
11. New model may pinpoint timing of final menstrual period
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2015)... 2015 Looking for a graduate ... impact your career? The Master of International Business, ... in multinational companies and for professionals seeking a ... global landscape, differences in culture, religion, government, and ... program develops the global competence and confidence needed ...
(Date:5/3/2015)... MA (PRWEB) May 03, 2015 SpineFrontier, ... clearance from the FDA to produce and market their ... device can be used in outpatient settings and is ... The alternate posterior approach has been extensively researched and ... 510k approval to use this approach in conjunction with ...
(Date:5/3/2015)... HealthPostures, a pioneering ergonomics company that ... the , May 5 - 7, 2015 Minnesota Safety ... the conference include its bestselling TaskMate sit stand solutions. ... 6100 TaskMate Executive. Features of the 6100 TaskMate Executive ... extended platform work surface and supply holders. Weighing 50 ...
(Date:5/2/2015)... Ticket Down has secured additional inventories of ... awaited event today, Saturday, May 2nd at the MGM Grand ... be able to secure tickets for both the actual fight ... fans have wanted for more than five years was finally ... will step inside the ring to fight Manny “Pac-Man” Pacquiao ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 “ ActOn ” ... which takes a look at the latest and coolest applications ... the host of AppWatch and technology expert, conducted the app ... to get connected with organizations to make a difference. , ... are very few things that aren’t about money, which is ...
Breaking Medicine News(10 mins):Health News:The Saint Louis University's Master of International Business Is Now Enrolling For Fall 2015 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 2Health News:Cheap Floyd Mayweather vs. Manny Pacquiao Tickets: Ticket Down Has Last Minute Tickets for Mayweather vs. Pacquiao at the MGM Grand Garden Arena in Las Vegas 3Health News:An Application to Help People Make a Difference Was Featured on NewsWatch Television 2
... is reason to believe that a gene-based treatment for heart ... of new blood vessels in hearts with severe hardening of ... thousands of patients suffering with heart disease.// ,Treatment ... surgical procedures that open blocked arteries and improve blood flow ...
... A new study from Brazil has found that coffee ... blood levels of cholesterol and the protein homocysteine.High levels ... disease. Some of the compounds, called terpenoids, are known ... Right, of Marylandl University Hospital ,US, explained that "it ...
... Children living in damp homes run greater asthma risks,say ... could double the risk of asthma, say researchers. ,A ... in damp homes not only increased the risk of ... repeated colds and skin allergies. People living in damp ...
... is an inherited blood disorder that affects red blood ... cells that contain an abnormal type of hemoglobin. Sometimes ... passing through small blood vessels. When sickle-shaped cells clump ... pain severe enough to require hospital admission. // ...
... has approved a new method to treat women suffering excessive ... the tissue at fault. Millions of women suffer menorrhagia, benign ... than 20 tampons in a single day. Thousands of women ... try hormone treatment.// ,The other option is to ...
... That's been the mantra of the media as dozens of ... clamor for the potent antibiotic. But if the supply dwindles, ... used, including a previous generation's wonder drug: penicillin. Although alternatives ... to get attention. , // ,It helped that ...
Cached Medicine News:
(Date:5/1/2015)...  Legendary actor and director Danny Glover ... designed to educate and encourage patients with neurologic conditions, ... (PBA) and to speak with their physician. The campaign ... ability to cry and laugh on cue and how ... people living with PBA episodes. While PBA ...
(Date:5/1/2015)... 1, 2015  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ), ... commercialization of innovative therapies for the treatment of acute ... Morris , chief financial officer  will be participating in ... as follows: Mizuho Third Annual Healthcare Corporate ... Berkshire Place, New York ...
(Date:4/30/2015)... 30, 2015 Omnicell, Inc. (NASDAQ: OMCL ), ... to healthcare systems, today announced results for its first ... Revenue for the first quarter of 2015 was $116.2 ... quarter of 2014, and down $5.3 million or 4.4% ... quarter 2015 net income as reported in accordance with ...
Breaking Medicine Technology:Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 2Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 3AcelRx Pharmaceuticals to Participate at Upcoming Investor Conferences in May 2Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20Omnicell Announces First Quarter 2015 Results 21Omnicell Announces First Quarter 2015 Results 22Omnicell Announces First Quarter 2015 Results 23Omnicell Announces First Quarter 2015 Results 24Omnicell Announces First Quarter 2015 Results 25Omnicell Announces First Quarter 2015 Results 26Omnicell Announces First Quarter 2015 Results 27
... 2011 Telik, Inc. (Nasdaq: TELK ) reported a ... three months ended December 31, 2010, compared with a net loss ... in 2009.  For the year ended December 31, 2010, net loss ... loss of $23.7 million, or $0.44 per share, for the year ...
... Amgen (Nasdaq: AMGN ) today announced ... study of 1,776 advanced cancer patients with different types ... or multiple myeloma, which compared XGEVA ™ (denosumab) ... The study, which appeared today in the Journal ...
Cached Medicine Technology:Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance 2Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance 3Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance 4Telik Announces Fourth Quarter and 2010 Year End Financial Results and 2011 Financial Guidance 5The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma 2The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma 3The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma 4The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma 5The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma 6The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma 7The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma 8
The opaque outer circle will white-out even the darkest iris, making your pupil the only spot of black in a sea of white....
This lens gives the appearance of mystery and mayhem behind the blackest of eyes....
Soft silicone brush tip allows atraumatic brushing and manipulation of retina surface. Silicone brush extends 3mm beyond end of cannula. Luer lock hub for easy, secure connection to a backflush handl...
Healon vitreous aspirating cannula, 21 gauge....
Medicine Products: